NextCure competitors

NextCure Competitors include Cesca Therapeutics, Celldex Therapeutics, Synthetic Biologics and Chimerix.
Add company...
NextCure
NextCure
NextCure is a biopharmaceutical company focused on discovering and developing next generation immuno-oncology-based drugs.
Cesca Therapeutics
Cesca Therapeutics
Cesca Therapeutics is engaged in the research, development, and commercialization of cell-based therapeutics for use in regenerative medicine.
Celldex Therapeutics
Celldex Therapeutics
Celldex is developing targeted therapeutics to address devastating diseases for which available treatments are inadequate.
Synthetic Biologics
Synthetic Biologics
Synthetic Biologics is a late-stage clinical company developing therapeutics designed to preserve the microbiome.
Chimerix
Chimerix
Chimerix is a biopharmaceutical company discovering, developing and commercializing medicines that improve outcomes for immunocompromised patients.
Founding Date
Founding Date
2015
Founding Date
1986
Founding Date
1983
Founding Date
2001
Founding Date
2000
Type
Type
Private
Type
Public
Type
Public
Type
Public
Type
Public
Tags
Locations
Locations
Beltsville, US HQ
Locations
Rancho Cordova, US HQ
Wuxi Shi, CN
Locations
Hampton, US HQ
Needham, US
Fall River, US
Branford, US
Locations
Rockville, US HQ
Locations
Durham, US HQ
Employees
Employees
N/A
Employees
95
Employees
1926% decrease
Employees
2414% decrease
Employees
826% decrease
Valuation ($)
Valuation ($)
N/A
Valuation ($)
6.7 m
Valuation ($)
49.8 m
Valuation ($)
276.8 k
Valuation ($)
146.6 m
Twitter followers
Twitter followers
N/A
Twitter followers
351
Twitter followers
N/A
Twitter followers
1.3 k
Twitter followers
884

Financial

Revenue (est.)
Revenue (est.)
N/A
Revenue (est.)
$14.5m (FY, 2017)
Revenue (est.)
$12.7m (FY, 2017)
Revenue (est.)
N/A
Revenue (est.)
$4.5m (FY, 2017)
Net income
Net income
N/A
Net income
($29.1m) (FY, 2017)
Net income
($93m) (FY, 2017)
Net income
($15.5m) (FY, 2017)
Net income
($71m) (FY, 2017)

Operating

Patents Issued
Patents Issued
N/A
Patents Issued
25 (FY, 2016)
Patents Issued
300 (FY, 2016)
Patents Issued
N/A
Patents Issued
N/A

Funding

Total funding raised
Total funding raised
$ 160m
Total funding raised
$ 15m
Total funding raised
$ 2m
Total funding raised
$ 16.1m
Total funding raised
N/A
For sources of this data, please see the company profileDownload Excel

View company profiles

Cesca Therapeutics
HQ
Rancho Cordova, US
Employees
95

Cesca Therapeutics is engaged in the research, development, and commercialization of cell-based therapeutics for use in regenerative medicine.

View company
Celldex Therapeutics
HQ
Hampton, US
Employees
192↓ 6% decrease

Celldex is developing targeted therapeutics to address devastating diseases for which available treatments are inadequate.

View company
Synthetic Biologics
HQ
Rockville, US
Employees
24↓ 14% decrease

Synthetic Biologics is a late-stage clinical company developing therapeutics designed to preserve the microbiome.

View company
Chimerix
HQ
Durham, US
Employees
82↓ 6% decrease

Chimerix is a biopharmaceutical company discovering, developing and commercializing medicines that improve outcomes for immunocompromised patients.

View company